ロード中...
Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in “Real Life”
Etelcalcetide is a new calcimimetic indicated for the treatment of secondary hyperparathyroidism (SHPT) in dialysis patients. Etelcalcetide efficacy in SHPT has been ascertained only in randomized controlled trials. This multicenter study was carried out in “real world” setting that is different fro...
保存先:
| 出版年: | J Clin Med |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6678718/ https://ncbi.nlm.nih.gov/pubmed/31330805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8071066 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|